TXNIP and acute myeloid leukemia: Seven single nucleotide polymorphisms (SNPs) of four immunomodulatory factors—HMOX1, TXNIP, TNSF10/TRAIL, and TNFAIP2—were selected and analyzed in 255 non-M3 AML patients and 316 healthy controls.